U.S. markets closed
  • S&P Futures

    3,846.25
    +12.00 (+0.31%)
     
  • Dow Futures

    30,975.00
    +66.00 (+0.21%)
     
  • Nasdaq Futures

    13,442.00
    +80.50 (+0.60%)
     
  • Russell 2000 Futures

    2,168.00
    +4.00 (+0.18%)
     
  • Crude Oil

    52.18
    -0.09 (-0.17%)
     
  • Gold

    1,854.30
    -1.90 (-0.10%)
     
  • Silver

    25.60
    +0.05 (+0.19%)
     
  • EUR/USD

    1.2171
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.0910
    -0.0180 (-1.62%)
     
  • Vix

    21.91
    +0.59 (+2.77%)
     
  • GBP/USD

    1.3689
    +0.0005 (+0.04%)
     
  • USD/JPY

    103.8000
    +0.0390 (+0.04%)
     
  • BTC-USD

    32,843.54
    +54.22 (+0.17%)
     
  • CMC Crypto 200

    669.64
    +59.65 (+9.78%)
     
  • FTSE 100

    6,695.07
    -20.35 (-0.30%)
     
  • Nikkei 225

    28,750.67
    +119.22 (+0.42%)
     

SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

·3 min read

NEW YORK, NY / ACCESSWIRE / January 4, 2021 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

  • American Renal Associates Holdings, Inc. (NYSE:ARA) relating to its acquisition by Nautic Partners, LLC. Under the terms of the agreement, ARA shareholders shall be entitled to receive $11.50 in cash for each share of ARA common stock owned. Click here for more information: https://www.monteverdelaw.com/case/american-renal-associates-holdings-inc. It is free and there is no cost or obligation to you.

  • Acamar Partners Acquisition Corp. (NASDAQ:ACAM) relating to its proposed merger with CarLotz, Inc. Under the terms of the agreement, ACAM shareholders will retain ownership of only 27% of the combined company. Click here for more information: https://www.monteverdelaw.com/case/acamar-partners-acquisition-corp. It is free and there is no cost or obligation to you.

  • Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) relating to its proposed acquisition by AstraZeneca, PLC. Under the terms of the agreement, Alexion shareholders will receive 2.1243 shares of AstraZeneca and $60.00 in cash per share. Click here for more information: https://www.monteverdelaw.com/case/alexion-pharmaceuticals-inc. It is free and there is no cost or obligation to you.

About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC



View source version on accesswire.com:
https://www.accesswire.com/623064/SHAREHOLDER-ALERT-Monteverde-Associates-Continues-to-Investigate-the-Following-Merger